Related Experiment Video

Updated: Aug 15, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Protective properties of synthetic peptides of outer meningococcal membrane

O V Kotelnikova1, O V Chibiskova, V A Nesmeyanov

  • 1MM Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow. ovkot.2003@mail.ru

Bulletin of Experimental Biology and Medicine
|October 15, 2005
PubMed

Insights

Synthesized peptide fragments from meningococcal outer membrane proteins PorA, OpaB, and NspA demonstrated significant protection in mice against serogroup B and A infections. A polycomponent preparation enhanced this protective effect, suggesting potential for a bivalent meningococcal vaccine.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Neisseria meningitidis serogroup B (MenB) poses a significant public health threat.
  • Outer membrane proteins like PorA, OpaB, and NspA are key targets for meningococcal vaccines.
  • Developing broadly protective vaccines against multiple serogroups remains a challenge.

Purpose of the Study:

  • To synthesize peptide fragments from conserved regions of PorA, OpaB, and NspA proteins.
  • To evaluate the protective efficacy of these peptides against serogroup B and A meningococcal infections in a mouse model.
  • To assess the potential of a polycomponent peptide preparation for a bivalent vaccine.

Main Methods:

  • Chemical synthesis of peptide fragments corresponding to conserved epitopes of PorA, OpaB, and NspA.
  • Immunization of mice with synthesized peptides.
  • Challenge of immunized mice with virulent strains of Neisseria meningitidis serogroups B and A.
  • Evaluation of survival rates and protective efficacy.

Main Results:

  • Synthesized peptides induced a significant protective immune response in mice.
  • Protection was observed against both homologous (serogroup B) and heterologous (serogroup A) strains.
  • A polycomponent preparation combining multiple peptides demonstrated an enhanced protective effect compared to individual peptides.

Conclusions:

  • Peptide fragments of conserved outer membrane proteins show promise as vaccine candidates against meningococcal disease.
  • A polycomponent approach utilizing these peptides could lead to a more effective bivalent (B+A) vaccine.
  • Further development of this peptide-based strategy may offer a new avenue for meningococcal disease prevention.

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification10:21

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Published on: November 16, 2016

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Outer Layers of the Cell Envelope01:18

Outer Layers of the Cell Envelope

The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers that firmly attach to the bacterial cell wall. Capsules are usually made of polysaccharides, though some are made of polypeptides. These...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...